Bekri S - Search Results

1

Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature.

Lidove O, Joly D, Barbey F, Bekri S, Alexandra JF, Peigne V, Jaussaud R, Papo T. Lidove O, et al. Among authors: bekri s. Int J Clin Pract. 2007 Feb;61(2):293-302. doi: 10.1111/j.1742-1241.2006.01237.x. Int J Clin Pract. 2007. PMID: 17263716 Review.

2

Implementation of a "hypoglycemia kit" in a pediatric emergency room: A retrospective study during 2011-2019.

Dulion F, Ducatez F, Tebani A, Sudrié-Arnaud B, Côme M, Auger M, Marret S, Bekri S. Dulion F, et al. Among authors: bekri s. Arch Pediatr. 2024 Jan;31(1):8-14. doi: 10.1016/j.arcped.2023.09.005. Epub 2023 Nov 21. Arch Pediatr. 2024. PMID: 37989664

3

Natural history of GM1 gangliosidosis-Retrospective cohort study of 61 French patients from 1998 to 2019.

Laur D, Pichard S, Bekri S, Caillaud C, Froissart R, Levade T, Roubertie A, Desguerre I, Héron B, Auvin S. Laur D, et al. Among authors: bekri s. J Inherit Metab Dis. 2023 Sep;46(5):972-981. doi: 10.1002/jimd.12646. Epub 2023 Jul 11. J Inherit Metab Dis. 2023. PMID: 37381921

4

Analysis of Enzyme Activity and Cellular Function for the N80S and S480F Asparagine Synthetase Variants Expressed in a Child with Asparagine Synthetase Deficiency.

Staklinski SJ, Snanoudj S, Guerrot AM, Vanhulle C, Lecoquierre F, Bekri S, Kilberg MS. Staklinski SJ, et al. Among authors: bekri s. Int J Mol Sci. 2022 Dec 29;24(1):559. doi: 10.3390/ijms24010559. Int J Mol Sci. 2022. PMID: 36613999 Free PMC article.

5

Fabry disease in patients with end-stage renal failure: the potential benefits of screening.

Bekri S, Enica A, Ghafari T, Plaza G, Champenois I, Choukroun G, Unwin R, Jaeger P. Bekri S, et al. Nephron Clin Pract. 2005;101(1):c33-8. doi: 10.1159/000085709. Epub 2005 May 9. Nephron Clin Pract. 2005. PMID: 15886492

6

[Fabry's disease in 2006: new treatment needs evaluation].

Lidove O, Bekri S, Andrès E. Lidove O, et al. Among authors: bekri s. Presse Med. 2006 Jun;35(6 Pt 1):933-5. doi: 10.1016/s0755-4982(06)74723-6. Presse Med. 2006. PMID: 16783249 French. No abstract available.

7

The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature.

Bekri S, Lidove O, Jaussaud R, Knebelmann B, Barbey F. Bekri S, et al. Cardiovasc Hematol Agents Med Chem. 2006 Oct;4(4):289-97. doi: 10.2174/187152506778520718. Cardiovasc Hematol Agents Med Chem. 2006. PMID: 17073606 Review.

8

[Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up].

Lidove O, Bekri S, Goizet C, Khau Van Kien A, Aractingi S, Knebelmann B, Choukroun G, Tsimaratos M, Redonnet-Vernhet I, Lacombe D, Jaussaud R. Lidove O, et al. Among authors: bekri s. Presse Med. 2007 Jul-Aug;36(7-8):1084-97. doi: 10.1016/j.lpm.2007.01.006. Epub 2007 Feb 2. Presse Med. 2007. PMID: 17276649 Review. French.

9

Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease.

Brakch N, Dormond O, Bekri S, Golshayan D, Correvon M, Mazzolai L, Steinmann B, Barbey F. Brakch N, et al. Among authors: bekri s. Eur Heart J. 2010 Jan;31(1):67-76. doi: 10.1093/eurheartj/ehp387. Epub 2009 Sep 22. Eur Heart J. 2010. PMID: 19773225 Free article.

10

[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech].

Lidove O, Choukroun G, Bekri S, Viot G, Tsimaratos M, Joly D. Lidove O, et al. Among authors: bekri s. Presse Med. 2010 May;39(5):527-9. doi: 10.1016/j.lpm.2010.01.002. Epub 2010 Mar 2. Presse Med. 2010. PMID: 20194001 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters